Lifeloc Technologies AI Stock Analysis
Want to see LCTC full AI Analyst Report?
Lifeloc Technologies (LCTC) AI Stock Analysis
Lifeloc Technologies
(Other OTC:LCTC)
Lifeloc Technologies earns a moderate overall score, heavily supported by strong technical momentum and a pristine, debt-free balance sheet. However, significant fundamental risks remain the primary headwind. Stagnant top-line growth and chronic unprofitability have led to poor valuation metrics and equity erosion. While recent investor presentations on new product pipelines offer a slight positive catalyst, the company must prove it can achieve sustainable net earnings to warrant a stronger rating.
Lifeloc Technologies (LCTC) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $9.63M
- Dividend Yield
- ―
- Average Volume (3M)
- 2,588
- Price to Earnings (P/E)
- -5.1
- Beta (1Y)
- 0.18
- Revenue Growth
- 9.13%
- EPS Growth
- -75.10%
- Country
- US
- Employees
- 37
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Hardware, Equipment & Parts
Lifeloc Technologies Business Overview & Revenue Model
Company Description
Lifeloc Technologies, Inc. develops, manufactures, and markets portable hand-held and fixed station breathalyzers and related accessories for law enforcement, workplace, corrections, original equipment manufacturing, and consumer markets worldwide. I...
How the Company Makes Money
Lifeloc Technologies makes money primarily by selling alcohol detection hardware and related products to commercial and governmental customers. Key revenue streams include: (1) Product sales of breath alcohol testing devices (e.g., handheld/portable...
Lifeloc Technologies Financial Statement Overview
Summary
Presents a mixed financial picture with a pristine, nearly debt-free balance sheet and improved trailing cash flows. However, this is heavily offset by stagnant revenues and persistent net losses that continue to erode equity.
Income Statement
30NegativeBalance Sheet
70PositiveCash Flow
60Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.27M | 9.03M | 8.54M | 9.33M | 8.48M | 7.05M |
| Gross Profit | 3.89M | 3.64M | 3.45M | 4.04M | 3.07M | 3.06M |
| EBITDA | -463.08K | -786.57K | -1.07M | 143.75K | 102.76K | 925.75K |
| Net Income | -2.07M | -2.47M | -1.05M | 205.61K | -455.76K | 675.97K |
Balance Sheet | ||||||
| Total Assets | 7.08M | 6.69M | 8.72M | 8.69M | 8.52M | 8.95M |
| Cash, Cash Equivalents and Short-Term Investments | 908.21K | 746.00K | 1.24M | 1.77M | 2.35M | 2.57M |
| Total Debt | 2.28M | 1.83M | 1.80M | 1.22M | 1.27M | 1.32M |
| Total Liabilities | 3.26M | 2.58M | 2.50M | 2.33M | 2.36M | 2.36M |
| Stockholders Equity | 3.82M | 4.10M | 6.23M | 6.36M | 6.16M | 6.59M |
Cash Flow | ||||||
| Free Cash Flow | 562.84K | -460.77K | -2.02M | -533.96K | -168.25K | -85.53K |
| Operating Cash Flow | 472.75K | 2,025 | -1.33M | -525.74K | 54.33K | 182.94K |
| Investing Cash Flow | -112.13K | -354.38K | -689.45K | -8,215 | -222.58K | -268.48K |
| Financing Cash Flow | 416.69K | 355.95K | 1.49M | -52.18K | -50.66K | 462.13K |
Lifeloc Technologies Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LCTC, the sentiment is Negative. The current price of 3.50 is below the 20-day moving average (MA) of 3.51, below the 50-day MA of 3.79, and above the 200-day MA of 2.94, indicating a neutral trend. The MACD of -0.08 indicates Negative momentum. The RSI at 38.09 is Neutral, neither overbought nor oversold. The STOCH value of 44.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LCTC.
Lifeloc Technologies Risk Analysis
Lifeloc Technologies disclosed 36 risk factors in its most recent earnings report. Lifeloc Technologies reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksLifeloc Technologies Peers Comparison
Overall Rating
- LCTC61Neutral
CPSH49Neutral
LINK46Neutral
KULR45Neutral
REFR39Underperform
SOBR38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| LCTC | 61Neutral | $9.39M | -5.11 | -47.35% | ― | 9.13% | -75.10% |
| CPSH | 49Neutral | $80.53M | 495.12 | 0.60% | ― | 7.01% | ― |
| LINK | 46Neutral | $48.05M | -44.60 | -10.97% | ― | 6.10% | 47.73% |
| KULR | 45Neutral | $84.69M | -0.89 | -97.97% | ― | 3.06% | -201.69% |
| REFR | 39Underperform | $12.45M | -4.39 | -221.11% | ― | -69.70% | -27.58% |
| SOBR | 38Underperform | $189.09K | -0.04 | -310.87% | ― | 17.67% | 92.17% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| LCTC | Lifeloc Technologies | 3.50 | 0.50 | 16.67% | |
| REFR | Research Frontiers | 0.32 | -1.31 | -80.56% | |
| CPSH | CPS Technologies Corp. | 4.06 | 0.69 | 20.47% | |
| LINK | Interlink Electronics, Inc. | 2.85 | -1.17 | -29.10% | |
| SOBR | Sobr Safe, Inc. | 0.04 | -2.20 | -98.39% | |
| KULR | KULR Technology Group | 1.72 | -0.82 | -32.28% |
Lifeloc Technologies Corporate Events
Lifeloc Technologies Highlights Growth at Lytham Investor Conference
PositiveOn September 28, 2026, Lifeloc Technologies announced it will participate in the virtual Lytham Partners Fall 2026 Investor Conference, scheduled for September 29-30, 2026. The company will deliver a webcast presentation on September 29 at 2:45 p.m....
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 29, 2026